A cellular fiber scaffold and its preparation method and application
By using Schwann cells differentiated from skin-derived precursor cells and cellular fiber scaffolds made of biodegradable materials, a mature vascular network was quickly constructed, which solved the problem of long angiogenesis construction cycle of tissue engineering tissues and organs, and significantly improved the surroundings Repair effect of nerve defects.
Patent Information
- Application Number
- CN202310008350.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-01-04
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-01-04
AI Technical Summary
The prior art has problems with long construction cycles, poor operability and high cost in the angiogenesis of tissue engineering tissue organs, especially in the repair of long-distance peripheral nerve defects, which lead to delayed nerve regeneration and poor effect.
Cytochemical fiber scaffolds were prepared by in vitro co-culture and transplanted subcutaneously in the host to quickly build mature vascular networks by using Schwan cells obtained from differentiation of skin-derived precursor cells. , combined with nerve catheter assembly to promote nerve regeneration.
It achieves faster and more complete prevascularization, improves local hypoxia, reduces immune rejection, and significantly improves the effect of nerve damage repair, shortens the preparation cycle, and improves the speed and effect of nerve regeneration.
Smart Images

Figure CN115944784B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine, and in particular relates to a cellularized fiber scaffold and a preparation method and application thereof. Background Art
[0002] Tissue engineering tissues and organs not only need to repair their morphology, but more importantly, they need to achieve their functionality, that is, the reconstruction of physiological performance. The rapid reconstruction of new vascular networks is the prerequisite for the survival of tissue engineering tissues and organs in the body, and is also the basis for the reconstruction of physiological performance. The bottleneck problem in the clinical application of tissue engineering is the angiogenesis of tissue engineering tissues and organs. The maximum free diffusion distance of oxygen is about 200µm. Once this distance is exceeded, new blood vessels need to be formed to provide oxygen to maintain the survival of tissues and organs. Therefore, how to quickly establish effective blood circulation with surrounding tissues after tissue engineering tissues and organs are implanted in the body is crucial to their own survival and the reconstruction of physiological performance.
[0003] At present, the research on vascularization of tissue-engineered nerves focuses on how to increase the number of new blood vessels during the in vivo repair process, that is, adding certain growth factors or supporting cells to enhance angiogenesis and thus promote nerve regeneration. For example, growth factors that promote angiogenesis, such as VEGF and bFGF, are directly added to tissue-engineered nerves, or seed cells, such as vascular endothelial cells, are added during the construction of tissue-engineered nerves, or stem cells or vascular endothelial cells differentiated from stem cells are implanted. In addition, physical or chemical modifications can be made to the biomaterial scaffold to further improve angiogenesis in the process of repairing nerve damage by tissue-engineered nerves. However, artificial nerve grafts without blood vessels are in a state of hypoxia in the process of repairing nerve regeneration, especially in the early stage of regeneration, which greatly slows down and restricts the speed and effect of nerve regeneration, especially for long-distance peripheral nerve defects.
[0004] Prevascularization of tissue-engineered nerves is a more promising research direction and construction strategy, which can further improve the clinical peripheral nerve injury repair effect. At present, there are still huge challenges in simulating complex natural and mature vascular systems in vitro. The most common method of using vascular endothelial cells (or endothelial cells derived from stem cell-induced differentiation) to construct a vascular network in vitro and then transplant it in vivo to anastomose with the host's vascular network has the disadvantage of obtaining a mature, stable, and long-term capillary network; even if a variety of cells can be used to construct a vascular network in vitro, the process involved is complicated, and the operability and controllability are poor. Compared with in vitro, it is simpler and more feasible to achieve prevascularization of tissue-engineered nerves by implantation in vivo, such as subcutaneous or intermuscular space, especially the mature and rich vascular network obtained in vivo can anastomose and recanalize with the body's blood vessels more quickly to alleviate local hypoxia. The existing methods of constructing prevascularized tissue-engineered nerves in vivo using one or two growth factors have the disadvantage of a long construction cycle, which requires at least 2 weeks of implantation time, increases costs and limits the scope of its clinical application. Therefore, finding a faster, more complete and more mature method for preparing prevascularized tissue-engineered nerves has very important practical and clinical significance. Summary of the invention
[0005] The purpose of the present invention is to provide a cellular fiber scaffold and a preparation method and application thereof.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] A cellularized fiber scaffold, comprising a fiber scaffold and supporting cells, wherein the supporting cells adhere to and / or wrap around the surface of the fiber scaffold;
[0008] The supporting cells are Schwann cells differentiated from skin-derived precursor cells;
[0009] The fiber scaffold is made of biodegradable materials, and the biodegradable materials are one or more of silk fibroin, chitosan, collagen, decellularized matrix, polylactic acid or polyglycolic acid.
[0010] The preparation method of the cellular fiber scaffold comprises the following steps:
[0011] Step 1, culturing supporting cells in vitro to obtain a supporting cell suspension;
[0012] Step 2, co-culturing the supporting cell suspension in step 1 with the fiber scaffold in vitro to obtain the cellularized fiber scaffold.
[0013] The application of the cellularized fiber scaffold in preparing pre-vascularized tissue engineering nerves.
[0014] A pre-vascularized tissue engineering nerve is prepared from the cellularized fiber scaffold.
[0015] The application of the above-mentioned pre-vascularized tissue engineering nerve in the preparation of peripheral nerve defect regeneration products.
[0016] A peripheral nerve defect regeneration product comprises a nerve conduit and the above-mentioned prevascularized tissue engineering nerve, wherein the prevascularized tissue engineering nerve is placed in the nerve conduit.
[0017] Furthermore, the nerve conduit is made of natural or synthetic biodegradable materials, and the biodegradable materials are one or more of silk fibroin, chitosan, collagen, decellularized matrix, polylactic acid or polyglycolic acid.
[0018] The nerve conduit described in the present invention is a tissue engineering nerve graft commonly used by those skilled in the art, preferably a chitosan conduit with a porous surface, such as a nerve conduit with a porous structure of 50-90%, a pore size of 50-300 mm, and high tensile strength, the inner diameter of the tubular body is 0.5-8 mm, and the wall thickness is 0.1-3 mm, which can be prepared by referring to the method described in patent application CN102343114A tissue engineering nerve graft and its use or patent application CN103041450A cell matrix modified tissue engineering nerve graft for repairing peripheral nerve injury and its preparation method; or preferably a nanofiber silk fibroin conduit, which can be prepared by referring to the method described in patent application CN101664346A artificial nerve graft prepared by electrospinning and its preparation method and special device or patent application CN103041450A cell matrix modified tissue engineering nerve graft for repairing peripheral nerve injury and its preparation method.
[0019] The preparation of the silk fiber described in the present invention can be prepared by referring to the method described in patent application CN101664346A for preparing an artificial nerve graft by electrospinning and its preparation method and dedicated device.
[0020] The present invention uses SKP-SCs that secrete angiogenic factors as supporting cells to construct a cell pre-vascularized fiber guide scaffold containing SKP-SCs, and transplants it into the host's subcutaneous tissue, thereby more quickly constructing a cell pre-vascularized tissue engineering nerve composed of a host-derived mature vascular network, a fiber scaffold, and a large number of surviving SKP-SCs. Afterwards, the cell pre-vascularized tissue engineering nerve is used to transplant and repair a long-distance defect of the sciatic nerve of a rat. On the one hand, it can achieve fusion with the host vascular network after transplantation, improve local hypoxia and regeneration microenvironment of the injury, and reduce the immune rejection reaction of the transplant; on the other hand, it can achieve the superposition effect of the dual factors of pre-generated blood vessels and supporting cells that promote nerve regeneration, thereby further improving the nerve injury repair effect; in addition, the fiber scaffold containing supporting cells is assembled with the nerve conduit after pre-vascularization, so that the dual factors of blood vessels and cells that promote nerve regeneration are gathered inside the lumen of the nerve conduit, thereby more accurately guiding Schwann cells and nerve axons to regenerate between the proximal and distal nerve trunks. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is the cell pre-vascularized tissue engineering nerve construction and application principle of the present invention.
[0022] Figure 2 The results of the experiment of supporting cell SKP-SCs expressing the main angiogenic factors in vitro. Among them: A is the in vitro culture pattern of SKP-SCs (GFP-SKP-SCs are SKP-SCs with green fluorescence, which is easy to distinguish and observe, and the rest are the same); BG are immunofluorescence staining images of SKP-SCs expressing the angiogenic factors VEGF, TGFb and bFGF.
[0023] Figure 3 The results of the experiment of supporting cells SKP-SCs promoting the proliferation, migration and tube formation of vascular endothelial cells in vitro. Among them: A is the in vitro co-culture model of SKP-SCs and vascular endothelial cells; BM is the typical pictures and index statistics of SKP-SCs affecting the proliferation, migration and tube formation of vascular endothelial cells.
[0024] Figure 4 The experimental results of preparing cellularized fiber scaffolds by co-culturing SKP-SCs and silk fiber scaffolds in vitro.
[0025] Figure 5 The results of the surface angiogenesis experiment of different groups of silk fiber scaffolds implanted subcutaneously. Among them: A is the pre-vascularization pattern of the fiber scaffold; B is the gross view of the surface blood vessels under a stereomicroscope of the fiber scaffolds implanted subcutaneously in different groups for 4 days, 7 days and 14 days; CF is the statistics of vascular indicators.
[0026] Figure 6The results of the internal angiogenesis experiment of different groups of silk fiber scaffolds implanted subcutaneously. Among them: A is the pre-vascularization pattern of the fiber scaffold; B is the anti-CD34 (blood vessel) immunofluorescence staining picture of the internal blood vessels of the fiber scaffolds implanted subcutaneously in different groups for 4 days, 7 days and 14 days; C-F'' is the statistics of blood vessel indicators.
[0027] Figure 7 The results are as follows: The migration distance of Schwann cells and the extension distance of proximal axons at the end of the nerve (proximal and distal) 4 and 14 days after different methods of prevascularized tissue-engineered nerve bridging to repair the sciatic nerve defect in rats. A is a model diagram of prevascularized tissue-engineered nerve bridging to repair the sciatic nerve defect in rats; BC are the statistics of Schwann cell and axon regeneration distances 4 and 14 days after different methods of prevascularized tissue-engineered nerve bridging to repair the nerve defect in vivo. DETAILED DESCRIPTION
[0028] Skin-derived precursor cells (progenitor cells) are a recently discovered stem cell with great clinical application potential. Different from other known skin stem cells, some studies believe that they are derived from the ectoderm and can better induce differentiation into nerve cells. The inventors isolated and purified skin-derived precursor cells (SKPs) from rat skin, and induced them to differentiate into Schwann cells (SKP-SCs); further in vitro tissue-engineered nerves were constructed with Schwann cells differentiated from skin precursor cells (SKP-SCs) as supporting cells and chitosan conduits with built-in silk fibers as scaffold materials. Afterwards, the new cell tissue engineering nerve was used to repair the sciatic nerve defect in rats, achieving an ideal nerve regeneration effect. The degree of recovery of the nerve tissue structure was significantly better than that of the chitosan nerve conduit and closer to the autologous nerve. SKP-SCs can secrete a large amount of growth factors, thereby greatly improving the local nerve regeneration microenvironment, including vascularization, which should be one of its main mechanisms for promoting nerve regeneration.
[0029] like Figure 1 As shown, the present invention uses SKP-SCs that secrete angiogenic factors as supporting cells to construct a cellular fiber scaffold containing SKP-SCs, and transplants it into the host's subcutaneous tissue, thereby more quickly constructing a cell pre-vascularized tissue-engineered nerve composed of a host-derived mature vascular network, a fiber scaffold, and a large number of surviving SKP-SCs. The cell pre-vascularized tissue-engineered nerve is then used to transplant and repair long-distance defects in rat sciatic nerves. On the one hand, it can achieve fusion with the host's vascular network after transplantation, improve local hypoxia and regeneration microenvironment of the injury, and reduce the immune rejection reaction of the transplant; on the other hand, it can achieve the superposition effect of the dual pro-nerve regeneration factors of pre-generated blood vessels and supporting cells, thereby further improving the nerve injury repair effect.
[0030] The content of the present invention specifically includes the following aspects:
[0031] (1) In vitro expression of pro-angiogenic factors and evaluation of angiogenesis by SKP-SCs and construction of cellularized fiber scaffolds
[0032] The ability of supporting cells SKP-SCs to express and secrete pro-angiogenic factors was determined by immunofluorescence staining of SKP-SCs cultured in vitro against the main pro-angiogenic factors VEGF, TGFb, and bFGF. The in vitro co-culture model of SKP-SCs and vascular endothelial cells was further used to detect and clarify the promoting effect of supporting cells SKP-SCs on angiogenesis. SKP-SCs were co-cultured with fiber scaffolds in vitro to allow supporting cells to adhere to and wrap around the surface of silk fibers to prepare cellularized fiber scaffolds.
[0033] (2) In vivo evaluation of angiogenesis and cell survival of SKP-SCs cellularized fiber scaffolds and selection of implantation time
[0034] The SKP-SCs cellularized fiber scaffolds were transplanted into the subcutaneous tissue of the rats for prevascularization. The amount of angiogenesis on the surface and inside of the cellularized fiber scaffolds was observed by gross observation under a stereomicroscope and immunofluorescence staining after tissue sections at different time points after implantation, and the survival of cells supported by the fiber scaffolds was also observed. Compared with non-cellularized fiber scaffolds and VEGF-infiltrated fiber scaffolds, the SKP-SCs cellularized fiber scaffolds were fully prevascularized and contained a large number of SKP-SCs after 4 days of subcutaneous pre-transplantation.
[0035] (3) Assembling prevascularized cell fiber scaffolds and nerve conduits to construct cell prevascularized tissue engineering nerves and to evaluate the regeneration of peripheral nerve defects
[0036] Standardized assembled cell prevascularized tissue-engineered nerves were used to repair 10 mm sciatic nerve defects in rats. Neural conduit artificial nerve grafts without in vivo prevascularization were selected as negative controls to repair sciatic nerve defects in rats, and VEGF in vivo prevascularized tissue-engineered nerves were selected as positive controls. Immunohistochemical fluorescence staining was used to measure and analyze the migration distance of Schwann cells at the nerve stump (proximal and distal) and the regeneration distance of proximal axons to evaluate the effect of cell prevascularized tissue-engineered nerves in repairing peripheral nerve defects 4 and 14 days after bridging surgery.
[0037] The present invention is further described in detail below in conjunction with the accompanying drawings and specific examples, but it should not be construed as limiting the present invention. Without departing from the spirit and substance of the present invention, the modification or replacement of the method, steps or conditions of the present invention all belong to the scope of the present invention. The experimental methods and reagents without specifying the specific conditions in the examples are all in accordance with the conventional conditions in the art.
[0038] The culture medium and formulation used in the following examples are as follows:
[0039] SKP medium: DMEM / F12 (3:1), 40 ng / mL FGF2, 20 ng / mL EGF, 2% B27 supplement;
[0040] SKP-SCs differentiation medium: DMEM / F12 (3:1), 40 ng / mL FGF2, 20 ng / mL EGF, 2% B27supplement, 5-10% FBS;
[0041] SKP-SCs culture medium: DMEM / F12 (3:1), 5 µm / mL forskolin, 50 ng / mL HRG, 2% N2supplement, 1-5% FBS;
[0042] Example 1
[0043] 1. Cultivation of skin-derived precursor cells (SKPs)
[0044] Take a 1-day-old SD rat and disinfect its skin with 75% alcohol. Move the rat to the sterile clean bench in the cell culture room and cut a 2 cm 2 Place the skin in pre-cooled DMEM / F12 (3:1) culture medium and remove all subcutaneous fat, blood vessels and other connective tissue layers. Transfer the processed skin into a centrifuge tube and cut the skin into 1mm 2 Skin fragments of different sizes. After rinsing with PBS twice, add preheated collagenase Ⅺ 3 times the volume of the skin and place in a 37°C, CO2 cell culture incubator for digestion for 45-60 minutes. During this period, blow once every 15 minutes. When the liquid becomes milky and / or chylous and the skin morphology disappears completely, add 10-15mL of digestion stop solution. Filter with a 400-mesh filter and rinse with 15mL DMEM / F12 (3:1). Collect all the filtrate and centrifuge at 1200 rpm for 7 minutes. Discard the supernatant, add 2mL DMEM / F12 (3:1) to resuspend the cells, and count them after trypan blue staining. Cells are divided into 10 5 The cells were seeded into SKP medium at a cell density of 1 mL / mL and cultured for 1-3 weeks, during which 1 mL of fresh SKP medium was added every 3 days to replenish all nutrient factors and the consumed medium.
[0045] 2. SKPs differentiate into Schwann cells
[0046] Transfer the culture medium of the suspended SKP cell sphere into a centrifuge tube and centrifuge at 1000 rpm for 3-5 minutes. After discarding the supernatant, add 0.5 mL of collagenase Ⅺ and digest at 37°C until the cells are dissociated into single cells. After digestion, centrifuge after termination. Resuspend the cells after centrifugation with SKP culture medium, count them after trypan blue staining, and count them at 10 6 / mL of cells were seeded into coated culture dishes containing SKP culture medium and placed in a 37°C, 5% CO2 incubator for 3 days. After 3 days, the culture medium was discarded and replaced with SKP-SCs differentiation medium for continued culture. The culture medium was replaced every 3 days until Schwann cells appeared and gradually proliferated into colonies with higher purity. 2 Scaled sterile filter paper pieces were soaked in 0.125% trypsin, and SKP-SCs colonies were carefully digested under a microscope. The cells were carefully collected and seeded in new coated culture dishes, and SKP-SCs culture medium (expanded) was used to continue the culture. After 2-3 times, SKP-SCs cells were evenly spread on the bottom of the dish. Depending on the growth conditions, the cells were subcultured every 2-3 generations. It takes 2-3 weeks.
[0047] 3. Evaluation of SKP-SCs expression of pro-angiogenic factors and promotion of angiogenesis in vitro
[0048] The small round glass slide was taken out and placed in a 24-well plate, and coated with 0.2mg / mL PDL+0.02mg / mL Laminin coating solution. SKP-SCs were resuspended in SKP-SCs culture medium, evenly seeded in a 24-well plate, and cultured in an incubator at 37°C and 5% CO2. After the cells covered about 80% of the bottom of the well plate, they were fixed with 4% PA and then immunofluorescently stained for the corresponding proteins, and observed and photographed using a fluorescence microscope. The expression and secretion of angiogenic factors by supporting cells SKP-SCs were observed and analyzed by immunofluorescent staining with anti-VEGF, TGFb and bFGF.
[0049] To further evaluate the angiogenesis-promoting ability of SKP-SCs, an in vitro co-culture model of SKP-SCs and human umbilical vein endothelial cells (HUVECs) was established using Transwell chambers to analyze the effects of SKP-SCs on the proliferation (EdU staining) and migration (crystal violet staining) of vascular endothelial cells. In addition, HUVECs in good condition were resuspended in ECM basal medium and cultured at 2.2×10 4 The cells were seeded at a density of 1.5 × 10 / well in a 96-well plate covered with Matrigel, and the supernatant of SKP-SCs after 24 h of culture was added. The cells were cultured for 6 h for planar tube formation analysis, and the images were taken under an inverted microscope and analyzed using ImageJ software for angiogenesis analysis.
[0050] like Figure 2As shown in the figure, the three secretory angiogenic factors were highly expressed at the protein level in SKP-SCs, and the distribution of the three growth factors in the cells also had slight differences. TGFb was significantly expressed in both the cell body and cell processes, while VEGF and bFGF were mainly expressed in the cell body.
[0051] like Figure 3 As shown in the figure, SKP-SCs significantly enhanced the proliferation and migration ability of HUVECs by secreting pro-angiogenic factors; and the tube-forming ability of HUVECs on the matrix gel plane was significantly enhanced, which was reflected in the number of connections, nodes, grids and total length (ImageJ software).
[0052] 4. Construction of SKP-SCs Cellularized Fiber Scaffold
[0053] The silk fiber scaffolds were coated with 0.2 mg / mL PDL + 0.02 mg / mL Laminin and placed in the incubator for 6 h before being washed 3 times with PBS (10 min). SKP-SCs were resuspended in SKP-SCs culture medium (1×10 7 / mL), cell suspension covering silk fiber scaffolds, add 40µL each, let it stand at 37ºC incubator for 4-6 hours, turn the silk fiber scaffold 180°, add 40 µL cell suspension, let it stand at 4-6 hours. Add SKP-SCs culture medium to cover the silk fiber scaffold, culture for 2 days, change to SKP-SCs culture medium containing 50µg / mL Vc, change the medium every 2 days, discard the culture medium after 12 days of culture and place it in PBS for later use.
[0054] like Figure 4 As shown, a large number of supporting cells SKP-SCs adhered and wrapped around the surface of the silk fiber scaffold in a head-to-tail manner.
[0055] Example 2
[0056] 1. In vivo evaluation of angiogenesis in prevascularized SKP-SCs-derived fibrous scaffolds
[0057] SKP-SCs cellularized silk fiber scaffolds were implanted subcutaneously for prevascularization. After deep intraperitoneal anesthesia, the dorsal skin of SD rats was cut open (about 1.5 cm opening), and the subcutaneous fascia was cut open with ophthalmic scissors. After blunt dissection, SKP-SCs cellularized fiber scaffolds, VEGF pre-infiltrated fiber scaffolds (VEGF pre-infiltrated fiber scaffolds as controls were prepared by infiltrating chitosan nerve conduits with built-in silk fibers in 1.0 μg / mL VEGF aqueous solution for 24 h) and blank group fiber scaffolds were placed in the subcutaneous fascial cavity. Prevascularized fiber scaffolds were carefully separated and collected 4d, 7d, and 14d after surgery. Surface neovascularization was observed under stereomicroscopy after gross clearing (50%, 75%, 85%, and 100% gradient glycerol aqueous solution), and internal neovascularization was observed by anti-endothelial cell (CD34) immunofluorescence staining of frozen sections (AngioTool software).
[0058] like Figure 5 As shown in the figure, the surface angiogenesis ability of the SKP-SCs-implanted stent is stronger, especially 4 days after implantation, a large number of new blood vessels have grown on the surface of the SKP-SCs-implanted stent; while the VEGF stent has only a few blood vessels, and the blank stent has almost no blood vessels, only a thin layer of connective tissue wrapping. From a dynamic perspective, the number of blood vessels on the stent surface decreased in the VEGF stent and blank stent groups from 7 days to 14 days after implantation, while the SKP-SCs stent continued to increase.
[0059] like Figure 6 As shown in the figure, the new blood vessels in the SKP-SCs scaffolds were significantly different from those in the VEGF scaffolds and blank scaffolds at each time point. At 4 days after implantation, a large number of blood vessels had penetrated the entire length of the fiber monofilaments; at this time, a small number of blood vessels were visible between the monofilaments at one end of the VEGF scaffold, while there were no blood vessels between the monofilaments of the blank scaffolds. The dynamic line graph more clearly illustrates the vascularization advantage of the SKP-SCs scaffolds. Consistent with the surface blood vessels, the SKP-SCs-seeded scaffolds always maintained a strong angiogenesis ability, while the angiogenesis ability of the other two groups began to weaken after 7 days.
[0060] 2. Evaluation of cell survival and implantation time of prevascularized SKP-SCs cellularized fiber scaffolds in vivo
[0061] By using GFP-SKP-SCs with green fluorescence, the survival of supporting cells after implantation in vivo was observed and tracked. 4 days after implantation, a large number of supporting cells still survived in the SKP-SCs cellularized fiber scaffold. Combined with the prevascularization situation, it was shown that 4 days of in vivo implantation could construct a fiber scaffold with sufficient prevascularization and a large number of supporting cells, which greatly shortened the preparation cycle compared with existing technologies and plans.
[0062] like Figure 6 As shown in the figure, 4 days after the cellularized fiber scaffold was implanted, there were still a large number of GFP-SKP-SCs adhering to and wrapping around the silk protein monofilaments, which decreased after 7 days and basically disappeared after 14 days.
[0063] Example 3
[0064] Evaluation of the effect of cell prevascularized tissue engineering nerve repair on peripheral nerve defect regeneration
[0065] A 10 mm sciatic nerve defect model was prepared in SD rats. SKP-SCs cell prevascularized tissue-engineered nerves (cellularized silk fibers were embedded in the lumen of chitosan nerve conduits), VEGF prevascularized tissue-engineered nerves (chitosan nerve conduits with embedded silk fibers were infiltrated in 1.0 μg / mL VEGF aqueous solution for 24 h and then implanted subcutaneously on the back of rats for 14 days), and non-prevascularized chitosan nerve conduits (chitosan nerve conduits with embedded silk fibers) were used to bridge and repair peripheral nerve defects. At 4 and 14 days after surgery, the regenerated nerve tissues of the bridged segments of each group were obtained for frozen sections after perfusion fixation. The migration of Schwann cells on both sides and the regeneration distance of proximal axons were measured by immunofluorescence staining of anti-Schwann cells (S100), axons (NF) and blood vessels (CD34) (ImageJ software) to evaluate the regenerative effect of SKP-SCs cell prevascularized tissue-engineered nerves in repairing peripheral nerve defects.
[0066] like Figure 7 As shown in the figure, at 4 and 14 days after surgery, Schwann cell migration and axon extension were slow in the control group due to slow growth of new blood vessels. Due to the prevascularization of SKP-SCs and VEGF, Schwann cells and axons migrated and regenerated rapidly along the pre-grown blood vessels. The farthest migration distance of bilateral Schwann cells and the extension distance of proximal axons showed that the regeneration effect of prevascularization in both groups was significantly better than that in the control group; moreover, the migration distance of Schwann cells and axon extension in the SKP-SCs prevascularization group was greater than that in the VEGF prevascularization group.
Claims
1. A peripheral nerve defect regeneration product, characterized in that: The invention comprises a nerve conduit and a prevascularized tissue-engineered nerve, wherein the prevascularized tissue-engineered nerve is placed in the nerve conduit; The pre-vascularized tissue engineering nerve is prepared by transplanting a cellularized fiber scaffold into the host's subcutaneous tissue for pre-vascularization. The cellularized fiber scaffold is prepared by the following steps: Step 1, culturing supporting cells in vitro to obtain a supporting cell suspension, wherein the supporting cells are Schwann cells SKP-SCs differentiated from skin-derived precursor cells; Step 2: The silk fiber scaffolds were coated with 0.2 mg / mL PDL and 0.02 mg / mL Laminin, placed in an incubator for 6 h, washed 3 times with PBS, and the SKP-SCs were resuspended in SKP-SCs culture medium to 1×10 7 / mL, cover the silk fiber scaffold with cell suspension, add 40µL to each, let it stand at 37ºC incubator for attachment for 4-6 h, turn the silk fiber scaffold 180°, add 40 µL of cell suspension, let it stand in the incubator for 4-6 h, add SKP-SCs culture medium to cover the silk fiber scaffold, culture for 2 days, change to SKP-SCs culture medium containing 50µg / mL Vc, change the medium every 2 days, discard the culture medium after 12 days of culture and place it in PBS for later use, and obtain the SKP-SCs cellular fiber scaffold.
2. The peripheral nerve defect regeneration product according to claim 1, characterized in that: The nerve conduit is made of biodegradable material, and the biodegradable material is one or more of silk fibroin, chitosan, collagen, decellularized matrix, polylactic acid or polyglycolic acid.
